Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Contraception. 2020 Aug 21;102(5):361–367. doi: 10.1016/j.contraception.2020.08.006

Table 4.

Simultaneous analysis of NES and endogenous steroid hormones in samples collected from women using a NES- and E2-releasing CVR (n=5).

Parameter NES E2 P4 E1
Assay Range (ng/mL) 0.010 – 10 0.010 – 10 0.010 – 10 0.010 – 10
Sample Concentration Range (median) (ng/mL) 0.014 – 1.471 (0.178) 0.010 – 0.312 (0.034) 0.010 – 5.791 (0.049) 0.010 – 0.416 (0.033)
Number of Sampes Quantified 550/615* 595/615 596/615 609/615
Number of Samples <LLOQ and >MDL 0/615** 17/615 18/615 6/615
Number of Samples <MDL 0/615** 3/615 1/615 0/615
*

the 65 baseline samples for each subject before administration of NES were not detected (<MDL).

**

does not include baseline samples

NES, Nestorone®; E2, estradiol; P4, progesterone; E1, estrone; LLOQ, lower limit of quantification; MDL, method detection limit.